Lilly Endowment reports 95,492,993 LLY shares with sole voting power
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Lilly Endowment, Inc. filed Amendment No. 43 to Schedule 13G reporting beneficial ownership of 95,492,993 shares of Eli Lilly (LLY) common stock, representing 10.1% of the class. The ownership is reported as of September 30, 2025, and the percentage is based on 946,456,759 shares outstanding as of August 4, 2025 per the issuer’s Form 10‑Q.
The Endowment has sole voting power and sole dispositive power over 95,492,993 shares, with no shared voting or dispositive power. The filer is an Indiana not‑for‑profit organization and private foundation.
Positive
- None.
Negative
- None.
FAQ
What stake in Eli Lilly (LLY) does Lilly Endowment report?
Lilly Endowment reports beneficial ownership of 95,492,993 shares, or 10.1% of Eli Lilly’s common stock.
As of what date are the ownership figures reported for LLY?
The ownership amounts are reported as of September 30, 2025.
What filing was made regarding LLY and by whom?
An Amendment No. 43 to Schedule 13G was filed by Lilly Endowment, Inc. regarding Eli Lilly common stock.